Literature DB >> 24025662

A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes.

Mónica Hernández Alava1, Allan Wailoo1, Fred Wolfe2, Kaleb Michaud2,3.   

Abstract

BACKGROUND: Analysts frequently estimate health state utility values from other outcomes. Utility values like EQ-5D have characteristics that make standard statistical methods inappropriate. We have developed a bespoke, mixture model approach to directly estimate EQ-5D. An indirect method, "response mapping," first estimates the level on each of the 5 dimensions of the EQ-5D and then calculates the expected tariff score. These methods have never previously been compared.
METHODS: We use a large observational database from patients with rheumatoid arthritis (N = 100,398). Direct estimation of UK EQ-5D scores as a function of the Health Assessment Questionnaire (HAQ), pain, and age was performed with a limited dependent variable mixture model. Indirect modeling was undertaken with a set of generalized ordered probit models with expected tariff scores calculated mathematically. Linear regression was reported for comparison purposes. Impact on cost-effectiveness was demonstrated with an existing model.
RESULTS: The linear model fits poorly, particularly at the extremes of the distribution. The bespoke mixture model and the indirect approaches improve fit over the entire range of EQ-5D. Mean average error is 10% and 5% lower compared with the linear model, respectively. Root mean squared error is 3% and 2% lower. The mixture model demonstrates superior performance to the indirect method across almost the entire range of pain and HAQ. These lead to differences in cost-effectiveness of up to 20%.
CONCLUSIONS: There are limited data from patients in the most severe HAQ health states. Modeling of EQ-5D from clinical measures is best performed directly using the bespoke mixture model. This substantially outperforms the indirect method in this example. Linear models are inappropriate, suffer from systematic bias, and generate values outside the feasible range.
© The Author(s) 2013.

Entities:  

Keywords:  EQ-5D; mapping; rheumatoid arthritis; statistical methods

Mesh:

Substances:

Year:  2013        PMID: 24025662     DOI: 10.1177/0272989X13500720

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  18 in total

1.  Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.

Authors:  Mónica Hernández Alava; Allan Wailoo; Stephen Pudney; Laura Gray; Andrea Manca
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

2.  Mapping CHU9D Utility Scores from the PedsQLTM 4.0 SF-15.

Authors:  Christine Mpundu-Kaambwa; Gang Chen; Remo Russo; Katherine Stevens; Karin Dam Petersen; Julie Ratcliffe
Journal:  Pharmacoeconomics       Date:  2017-04       Impact factor: 4.981

3.  Mapping between HAQ-DI and EQ-5D-5L in a Chinese patient population.

Authors:  Thomas Patton; Hao Hu; Luan Luan; Keqin Yang; Shu-Chuen Li
Journal:  Qual Life Res       Date:  2018-07-04       Impact factor: 4.147

4.  Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.

Authors:  Hye-Lin Kim; Dam Kim; Eun Jin Jang; Min-Young Lee; Hyun Jin Song; Sun-Young Park; Soo-Kyung Cho; Yoon-Kyoung Sung; Chan-Bum Choi; Soyoung Won; So-Young Bang; Hoon-Suk Cha; Jung-Yoon Choe; Won Tae Chung; Seung-Jae Hong; Jae-Bum Jun; Jinseok Kim; Seong-Kyu Kim; Tae-Hwan Kim; Tae-Jong Kim; Eunmi Koh; Hwajeong Lee; Hye-Soon Lee; Jisoo Lee; Shin-Seok Lee; Sung Won Lee; Sung-Hoon Park; Seung-Cheol Shim; Dae-Hyun Yoo; Bo Young Yoon; Sang-Cheol Bae; Eui-Kyung Lee
Journal:  Rheumatol Int       Date:  2016-02-06       Impact factor: 2.631

Review 5.  Is Meta-Analysis for Utility Values Appropriate Given the Potential Impact Different Elicitation Methods Have on Values?

Authors:  Tessa Peasgood; John Brazier
Journal:  Pharmacoeconomics       Date:  2015-11       Impact factor: 4.981

Review 6.  Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database.

Authors:  Helen Dakin
Journal:  Health Qual Life Outcomes       Date:  2013-09-05       Impact factor: 3.186

Review 7.  Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury: A Systematic Review and Mapping Study.

Authors:  Gordon Ward Fuller; Monica Hernandez; David Pallot; Fiona Lecky; Mathew Stevenson; Belinda Gabbe
Journal:  Value Health       Date:  2016-12-28       Impact factor: 5.725

8.  Direct Mapping of the QLQ-C30 to EQ-5D Preferences: A Comparison of Regression Methods.

Authors:  Ralph Crott
Journal:  Pharmacoecon Open       Date:  2018-06

9.  Modelling the relationship between the WOMAC Osteoarthritis Index and EQ-5D.

Authors:  Allan Wailoo; Monica Hernandez Alava; Antonio Escobar Martinez
Journal:  Health Qual Life Outcomes       Date:  2014-03-12       Impact factor: 3.186

10.  Development of Methods for the Mapping of Utilities Using Mixture Models: Mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in Patients with Asthma.

Authors:  Laura A Gray; Mónica Hernández Alava; Allan J Wailoo
Journal:  Value Health       Date:  2017-12-14       Impact factor: 5.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.